Quality of Life Among Long-Term Survivors of Resected Gastric Cancer

CompletedOBSERVATIONAL
Enrollment

212

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Gastric Cancer
Interventions
BEHAVIORAL

EORTC QLQ-C30, QLQ-STO22, and MSK-10

QLQ-C30 is the generic QOL tool for patients with cancer undergoing clinical trials.QLQ-STO22, containing 22 questions specific to gastric cancer, is currently the only standardized disease-specific questionnaire to measure the QOL of gastric cancer and must be used in conjunction with the QLQ-C30.MSK-10 consists of ten additional questions that were developed by surgeons on the GMT service to answer specific questions about outcomes related to proximal subtotal, distal subtotal, and total gastrectomies. These questions focus on eating capabilities, work status and major life changing events.

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER